Searched for
GSK
Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities plunged on Monday as the Sensex fell 1,124 points and Nifty dropped over 360 points, wiping out nearly Rs 8 lakh crore in m...
- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
- Bharat Biotech is 'back in action' after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s nextBharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...
- Novartis India MD Amitabh Dube appointed as OPPI presidentAmitabh Dube has been appointed as the new president of OPPI for a two-year term. Dube currently serves as the Country President and Managi...
- Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in USLannett Company, part of Aurobindo Pharma, has launched generic Advair Diskus in the US, making it the first complex inhalation product fro...
- Mahajan Imaging, Neuberg Diagnostics join hands to scale pathology, genomics in North IndiaMahajan Imaging and Neuberg Diagnostics have formed a strategic joint venture. This partnership aims to expand pathology and genomics servi...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Laurus Labs among 5 stocks hitting 52-week highs; surge up to 20% in a monthSix BSE 200 stocks hit fresh 52-week highs on Friday as the Sensex gained 331 points. Coforge, GSK Pharma, Glenmark Pharma, Laurus Labs, Or...
- Solar Industries among 5 stocks hitting 52-week highs; surge up to 22% in a monthFive BSE 200 stocks hit fresh 52-week highs on Thursday despite a weak market. Divi’s Laboratories led the pack with a 22% monthly gain.
- Ahead of Market: 10 things that will decide stock market action on MondayIndian equities ended marginally higher on Friday as gains in financials, metals and small-caps offset pressure from IT stocks and persiste...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities extended losses for a seventh session as rising oil prices and US-Iran tensions heightened risk aversion. Nifty fell to 24,...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities extended losses as fading Middle East peace hopes, elevated crude prices, rising US yields and weak global cues intensified...
- Ajanta Pharma among 5 midcap stocks to hit 52-week highs & surge up to 18% in a monthFive BSE Midcap stocks—KEI Industries, GSK Pharmaceuticals, Lenskart Solutions, Radico Khaitan and Ajanta Pharma—hit fresh 52-week highs de...
- Trump’s vaccine overhaul could bring more shots, higher costs for US familiesPresident Donald Trump's vaccine plan faces significant financial and logistical hurdles. Drugmakers must develop new manufacturing process...
- Q1 earnings this week: SBI, Trent, Nykaa among 573 companies set to announce June quarter resultsThis week, 573 companies will announce their June quarter results, featuring prominent firms. Bharti Airtel and Nykaa are among those repor...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- GSK's Jemperli meets main goal in mid-stage rectal cancer trialGSK's cancer drug Jemperli met a key goal in a mid-stage trial. This drug targets a specific rectal cancer subtype affecting a small percen...
- GSK sends notices to Akums, Associate over 'Zinetac' brandThe Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...
- Pfizer to exit GSK's consumer health arm Haleon after spin-offBefore the spinoff, the holding company for the consumer health business will pay dividends to GSK and Pfizer. That will translate to GSK r...
Load More
